Circulating tumor DNA levels a few weeks after immunotherapy initiation could help identify patients with melanoma at greatest risk for recurrence or death.A retrospective analysis showed individuals ...

LAG-3 and TIGIT expression may predict skin melanoma progression and survival. Discover how these immune markers could shape future therapies. Read more.

In multivariable analysis, six clinicopathologic variables were significantly associated with time to recurrence: ulceration, tumor thickness, tumor location, neurotropism (tumor growth along nerves), ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at ...

DEAR DR. ROACH: Can you define the characteristics of the four stages of cancer? I understand that stage I is generally when cancer is caught early and can be treated with a good success rate, while ...

Melanoma in situ (MIS), also called stage 0 melanoma, is the earliest stage of melanoma, when the cancer is confined to the outermost layer of skin. Most melanomas affect the skin, but they can also ...

Investigators sought to determine whether adjuvant pembrolizumab is associated with the risk of developing subsequent cutaneous malignant neoplasms in patients with high-risk stage II melanoma.